BMC Cancer (Mar 2020)

Primary malignant pericardial tumour in Lynch syndrome

  • Pasquale Paolisso,
  • Giulia Saturi,
  • Alberto Foà,
  • Maristella Saponara,
  • Margherita Nannini,
  • Maria Abbondanza Pantaleo,
  • Ornella Leone,
  • Daniela Turchetti,
  • Daniele Calistri,
  • Carlo Savini,
  • Davide Pacini,
  • Carmine Pizzi,
  • Nazzareno Galiè

DOI
https://doi.org/10.1186/s12885-020-6677-y
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Background This case represents the first report of malignant primary cardiac tumour in a patient with Lynch Syndrome associated with MSH2 pathogenic variant. Case presentation A 57-year-old woman with previous ovarian cystadenocarcinoma was admitted to the emergency room for hematic pericardial effusion. Multimodal diagnostic imaging revealed two solid pericardial vascularized masses. After pericardiectomy, the final histological diagnosis was poorly differentiated pleomorphic sarcomatoid carcinoma. During follow-up she developed an ampulla of Vater adenocarcinoma. Genetic analysis identified an MSH2 pathogenic variant. Conclusion This case contributes to expand the tumour spectrum of Lynch syndrome, suggesting that MSH2 pathogenic variants cause a more complex multi-tumour cancer syndrome than the classic Lynch Syndrome. In MSH2 variant carriers, symptoms such as dyspnoea and chest discomfort might alert for rare tumours and a focused cardiac evaluation should be considered.

Keywords